DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Forward Printable StoryPrint Comment



Oncology Homepage

Carestream Health exhibiting medical imaging products at ASMIRT

QCCA evolves to become the first national clinically integrated network in Oncology

Varian ARIA Oncology Information System earns ONC Health IT Certification from Drummond Group LLC

Bolivian government invests in state-of-the-art cancer care from Elekta

Hospital charges for outpatient cancer care highly variable, Medicare billing records show

Global radiation dose to reach an estimated $3,066.1 million by 2025

American Cancer Society and Global Center for Medical Innovation partner to accelerate pace of bringing research to clinic

Mirada releases DLCExpert AI autocontouring software for radiation oncology

Varian ARIA, Eclipse and TrueBeam named Category Leaders in the 2018 Best in KLAS: Software and Services Report

Liquid biopsy can help predict outcomes in metastatic triple-negative breast cancer

SCOUT radar localization system demonstrated at Lynn Sage Breast Cancer Symposium

Press releases may be edited for formatting or style
ALISO VIEJO, CALIF., 14 September 2017 – Cianna Medical, Inc., today announced that its next-generation SCOUT radar localization system featuring real-time distance measurement will be exhibited for the first time at the Lynn Sage Breast Cancer Symposium in Chicago, IL, September 14-17, 2017.

The next-generation SCOUT technology advances the power of RADAR for breast tumor localization, making it the most precise and broadly applicable localizing system in the industry. It is clinically proven to be both consistent and predicable, and both physicians and patients will benefit from its unprecedented 60 mm range and 360˚ signal detection with +/- 1 mm accuracy. The real-time distance measurement and instant signal response will make it easier for surgeons to locate non-palpable tumors during breast surgery.

Story Continues Below Advertisement

Ventilators Plus -The Easy #1 Choice In Ventilator Sales, Rentals & Support

Our name says it all! Ventilators Plus is a full service depot repair facility offering on-site service as well. We BUY, SELL & RENT all models & also have a FULLY STOCKED parts warehouse available online 24/7. Call 888-889-2992.

SCOUT, an FDA-cleared localization system, is the world’s only technology that utilizes radar in human tissue, and it is changing the standard of care for breast tumor localization. Previously published data established SCOUT as an accurate and reliable method to localize and excise breast lesions. SCOUT has been quickly adopted at over 150 leading medical facilities across the United States, and it has been used in more than 16,000 patient procedures to date.

Alice Police, M.D., breast surgeon, University of California, Irvine, recently completed validation of the next-generation SCOUT system that will measure and display distance in millimeters. “SCOUT is the standard of care for all my breast lesion localizations. The distance feature provides more control over the procedure, which is important for predictable outcomes,” Dr. Police stated.

The Lynn Sage Breast Cancer Symposium is a multidisciplinary event that brings together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer.

The FDA-cleared SCOUT system features a proprietary, highly sophisticated reflector that is precisely placed at the tumor site up to 30 days before a lumpectomy or surgical biopsy. During the procedure, the surgeon scans the breast using the SCOUT guide which emits 50 million pulses per second, allowing the surgeon to “lock” in on the reflector’s precise location with ± 1mm of accuracy. This higher level of localization precision allows better surgical planning that may improve cosmetic results, as less tissue may need to be removed. SCOUT has an exceptional detection range of 1mm – 60mm, documented migration of <2% across multiple studies, and is OR compatible.

• Cianna Medical

Oncology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.